Supplement
Arginine is an amino acid the body uses to build proteins and to make nitric oxide, a molecule that relaxes blood vessels and helps blood flow. People mostly look at it for intermittent claudication, the leg pain that comes on with walking, and one small trial of 39 people found blood flow went up, though the evidence is limited. Results for related symptoms were mixed, so this is early, small-scale work that can't say much yet.
Sources: PMID 9809945
- Updated
- How we grade
- 17 studies cited
- Best evidence
- Grade C
- Conditions studied
- 15
- Outcomes
- 80
- Graded outcomes
- 00106
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
General Cardiovascular Health
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow Small Increase | Improves (the measure goes up) | Small effect | 1 study | 61 people | ||
| Asymmetric dimethylarginine (aka ADMA) No effect | NoneNo effect | 44 people | ||||
Muscle Size Strength
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow Small Increase | Improves (the measure goes up) | Small effect | 1 study | 17 people | ||
Intermittent Claudication
- Blood Flow: improves
- Nitric Oxide: improves
- Intermittent Claudication Symptoms: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow Small Increase | Improves (the measure goes up) | Small effect | 1 study | 39 people | ||
| Nitric Oxide | Improves (the measure goes up) | 4 studies | 39 people | |||
Studies that measured nitric oxide
| ||||||
| Intermittent Claudication Symptoms | Changes; see studies | 39 people | ||||
Peripheral Arterial Occlusive Disease
- Blood Flow: improves
- Intermittent Claudication Symptoms
- Nitric Oxide: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow Small Increase | Improves (the measure goes up) | Small effect | 1 study | 39 people | ||
| Intermittent Claudication Symptoms Mixed effect | 39 people | |||||
| Nitric Oxide | Improves (the measure goes up) | 4 studies | 39 people | |||
Studies that measured nitric oxide
| ||||||
Muscle Size & Strength
- Blood Flow: improves
- Heart Rate: changes; see studies
- Vascular Function: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow Small Increase | Improves (the measure goes up) | Small effect | 1 study | 17 people | ||
| Heart Rate | Changes; see studies | 1 study | 33 people | |||
| Vascular Function | Improves (the measure goes up) | 1 study | 17 people | |||
Studies that measured vascular function | ||||||
| Blood Pressure | Changes; see studies | 17 people | ||||
| Power Output | Improves (the measure goes up) | 16 people | ||||
General Athletic Performance
- Anaerobic Capacity: improves
- Nitric Oxide: improves
- Growth Hormone: improves
Type 2 Diabetes
- Adiponectin: improves
- Nitric Oxide: improves
- Plasma Arginine: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin Small Increase | Improves (the measure goes up) | Small effect | 33 people | |||
| Nitric Oxide | Improves (the measure goes up) | 4 studies | 33 people | |||
Studies that measured nitric oxide
| ||||||
| Plasma Arginine | Improves (the measure goes up) | 2 studies | 144 people | |||
| Blood Flow | Improves (the measure goes up) | 1 study | 144 people | |||
| Blood glucose | Changes; see studies | 1 study | 144 people | |||
Studies that measured blood glucose | ||||||
| Insulin | Changes; see studies | 1 study | 144 people | |||
| Vascular Function | Improves (the measure goes up) | 1 study | 33 people | |||
| Anti-Oxidant Enzyme Profile | Improves (the measure goes up) | 33 people | ||||
| Blood Pressure | Changes; see studies | 144 people | ||||
| Body Fat | Changes; see studies | 144 people | ||||
| Endothelin-1 | Improves (the measure goes up) | 33 people | ||||
| Glycemic Control | Improves (the measure goes up) | 144 people | ||||
| HbA1c | Changes; see studies | 144 people | ||||
| Muscle Mass | Improves (the measure goes up) | 144 people | ||||
Obesity
- Adiponectin: improves
- Nitric Oxide: improves
- Vascular Function: improves
Anaerobic Exercise Performance
- Anaerobic Capacity: improves
- Nitric Oxide: improves
- Oxygen Cost of Exercise: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anaerobic Capacity Small Improvement | Improves (the measure goes up) | Small effect | 9 people | |||
| Nitric Oxide | Improves (the measure goes up) | 4 studies | 9 people | |||
Studies that measured nitric oxide
| ||||||
| Oxygen Cost of Exercise | Improves (the measure goes up) | 9 people | ||||
Metabolic Health
- Ammonia
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Ammonia No effect | NoneNo effect | 10 people |
High Cholesterol
- C-Reactive Protein (CRP)
- Total cholesterol: changes; see studies
- Triglycerides: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) No effect | NoneNo effect | 643 people | ||||
| Total cholesterol | Changes; see studies | 1 study | 643 people | |||
Studies that measured total cholesterol | ||||||
| Triglycerides | Changes; see studies | 1 study | 643 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 643 people | ||||
| Low-density lipoprotein (LDL) | Changes; see studies | 643 people | ||||
| TNF-Alpha | Changes; see studies | 643 people | ||||
Cycling Performance
- Ammonia
- Nitric Oxide: improves
- Growth Hormone: improves
Dyslipidemia
- C-Reactive Protein (CRP)
- Total cholesterol: changes; see studies
- Triglycerides: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) No effect | NoneNo effect | 643 people | ||||
| Total cholesterol | Changes; see studies | 1 study | 643 people | |||
| Triglycerides | Changes; see studies | 1 study | 643 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 643 people | ||||
| Low-density lipoprotein (LDL) | Changes; see studies | 643 people | ||||
| TNF-Alpha | Changes; see studies | 643 people |
Peripheral Arterial Disease
- Asymmetric dimethylarginine (aka ADMA)
- Nitric Oxide: improves
- Plasma Arginine: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Asymmetric dimethylarginine (aka ADMA) No effect | NoneNo effect | 133 people | ||||
| Nitric Oxide | Improves (the measure goes up) | 4 studies | 38 people | |||
| Plasma Arginine | Improves (the measure goes up) | 2 studies | 133 people | |||
| Blood Flow | Improves (the measure goes up) | 1 study | 133 people | |||
| Blood glucose | Changes; see studies | 1 study | 38 people | |||
| Oxidative Stress Biomarkers | Changes; see studies | 1 study | 38 people | |||
| HbA1c | Changes; see studies | 38 people | ||||
| Intermittent Claudication Symptoms | Changes; see studies | 133 people | ||||
| Subjective Well-Being | Improves (the measure goes up) | 133 people |
Healthy Muscle Aging
- Growth Hormone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Growth Hormone | Improves (the measure goes up) | 3 studies | 28 people |
Key findings
- Blood FlowImproves (the measure goes up)
- Anaerobic CapacityImproves (the measure goes up)
- AdiponectinImproves (the measure goes up)
Shop Arginine
Third-party tested Arginine products. The evidence above is limited, so read it before you buy.
- Grade C
Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure
Studies cited
17 studies from PubMed
- Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial
- Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients
- The effect of oral L-arginine supplementation on fasting glucose, HbA1c, nitric oxide and total antioxidant status in diabetic patients with atherosclerotic peripheral arterial disease of lower extremities
- A study of growth hormone release in man after oral administration of amino acids
- Growth hormone responses to varying doses of oral arginine
- No effect of short-term arginine supplementation on nitric oxide production, metabolism and performance in intermittent exercise in athletes
- L-arginine supplementation in peripheral arterial disease: no benefit and possible harm
- Effects of 7 days of arginine-alpha-ketoglutarate supplementation on blood flow, plasma L-arginine, nitric oxide metabolites, and asymmetric dimethyl arginine after resistance exercise
- Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism
- Hemodynamic and vascular response to resistance exercise with L-arginine
- L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship
- Effect of L-Arginine supplementation on lipid profiles and inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.
- Oral arginine does not stimulate basal or augment exercise-induced GH secretion in either young or old adults
- Acute L-arginine alpha ketoglutarate supplementation fails to improve muscular performance in resistance trained and untrained men
- Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease
- Influence of chronic supplementation of arginine aspartate in endurance athletes on performance and substrate metabolism - a randomized, double-blind, placebo-controlled study
- The effect of l-arginine supplementation on lipid profile: a systematic review and meta-analysis of randomised controlled trials.